Molecular Diagnostics





Imaging and Blood Test Work Together to Optimize Evaluation of Ovarian Cancer Risk
A new US Food and Drug Administration-cleared blood test that measures the levels of five proteins and then uses a proprietary algorithm and software to calculate a single risk score has been the topic of recent research comparing the test to two imaging modalities. More...15 Apr 2014
In Other News
American Diagnostic Laboratory Offers Genetic Test for Calreticlin Gene Mutations
Microarray Gene Expression Approach May Help Predict Cancer Patient Survival
A Specific Mutation Links Some Forms of Inherited Melanoma
Genetic Cause Found for Rare Aggressive Ovarian Cancer
New Genetic Disease Identified in Children
New Blood Test to Provide Safe, Early Prenatal Genetic Screening
Assay Detects Tumor-Specific Gene Amplifications in ctDNA
Gene Test Predicts Melanoma Metastases
Gene Profile Predicts Risk of Bladder Cancer Recurrence
Novel DNA Test Evaluates Recurrent Pregnancy Loss
Gene Fusion Identified as Cause of Rare Thyroid Cancer
Genetic Clue to Irritable Bowel Syndrome Found
Proteomic Profiling Enables Earlier Diagnosis of Pancreatic Cancer
FDA Clears First-of-Its-kind Postnatal Test for Developmental Disabilities
New Gene Linked to Key Heart Attack Risk Factor
Fluorescent In Situ Sequencing Helps Diagnose Sick Tissues Early
Highly Specific Blood Test Detects Creutzfeldt-Jakob Disease
Preleukemic Hematopoietic Stem Cells Identified in Acute Leukemia
Combined Screening Suggested to Better Detect ALK Rearrangements in Samples from Non-Small-Cell Lung Cancer Patients
High Diagnostic Accuracy Demonstrated for New Kidney Cancer Test
Genetic Markers Found for Breast Cancer Brain Metastasis
Genomic Assay Predicts Probability of Heart Transplant Rejection
Gene Discovery Illuminates Cause of Bone Marrow Failure
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







